Landin B
Department of Clinical Chemistry, Malmö General Hospital, University of Lund, Sweden.
Hemoglobin. 1993 Jun;17(3):201-8. doi: 10.3109/03630269308998894.
An abnormal variant comprising approximately 39% of total hemoglobin was found in a 48-year-old Swedish woman. The variant was eluted from ion exchange high performance liquid chromatography (HPLC) used for routine quantification of Hb A1c at a position similar to Hb S. Amplification of beta-globin exons and nucleotide sequencing revealed heterozygosity for a GAT-->CAT mutation in codon 21, corresponding to the amino acid substitution Asp-->His at position 21. This mutation was confirmed by amino acid composition and peptide sequence determinations. Substitutions in this position are not likely to affect the function of the hemoglobin molecule and the hemoglobin variant, for which the name Hb Karlskoga is proposed, was not associated with any overt hematological abnormalities.
在一名48岁的瑞典女性中发现了一种异常变体,约占总血红蛋白的39%。该变体从用于常规糖化血红蛋白(Hb A1c)定量的离子交换高效液相色谱(HPLC)中洗脱出来,其位置与血红蛋白S(Hb S)相似。β-珠蛋白外显子的扩增和核苷酸测序显示,第21密码子存在GAT→CAT突变的杂合性,对应于第21位氨基酸天冬氨酸(Asp)→组氨酸(His)的替换。通过氨基酸组成和肽序列测定证实了这一突变。该位置的替换不太可能影响血红蛋白分子的功能,这种血红蛋白变体被命名为Hb Karlskoga,未发现任何明显的血液学异常。